Literature DB >> 7589259

Degradation of fibronectin fibrils by matrilysin and characterization of the degradation products.

D C von Bredow1, R B Nagle, G T Bowden, A E Cress.   

Abstract

Matrilysin is a metalloproteinase expressed in a variety of tumors as well as in some types of normal tissue. In addition to regulating normal tissue remodelling, metalloproteinases are believed to play a role in tumor cell invasion and metastasis by degrading components of the extracellular matrix, for example the highly insoluble fibronectin fibrils found in the interstitial stroma. In this study we examined whether matrilysin can degrade fibronectin fibrils produced by human foreskin fibroblasts and characterized the degradation products of soluble fibronectin. Using indirect immunofluorescence microscopy, we demonstrate for the first time degradation of the fibronectin fibrils upon incubation with 15 nM active matrilysin. Removal of matrilysin resulted in regrowth of the fibrils, suggesting that matrilysin was not cytotoxic. Immunoblotting with specific monoclonal antibodies revealed initial degradation of soluble fibronectin within 1 h. Further degradation occurred over a period of 20 h. Degradation of soluble fibronectin resulted in one fragment of 58 kDa containing the gelatin-binding domain, two fragments of 37 and 38 kDa, which were part of the cell attachment domain, and three fragments of 36, 33, and 30 kDa recognized by an antibody raised against the C-terminal heparin-binding domain. In addition to most of these fragments, several intermediates and unique fragments of 31 and 34 kDa could be found in the conditioned medium of human foreskin fibroblasts treated with matrilysin. Isolation of these fragments may allow further studies to determine their influences on cell migration, attachment, and signal transduction, which are expected to be different from the effects of undegraded fibronectin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589259     DOI: 10.1006/excr.1995.1355

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

2.  Proteomic analysis of the left ventricle post-myocardial infarction to identify in vivo candidate matrix metalloproteinase substrates.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Lisandra E de Castro Brás; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  Methods Mol Biol       Date:  2013

3.  In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics.

Authors:  Ying Ann Chiao; Rogelio Zamilpa; Elizabeth F Lopez; Qiuxia Dai; Gladys P Escobar; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

Review 4.  Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Authors:  Kristine Y DeLeon-Pennell; Cesar A Meschiari; Mira Jung; Merry L Lindsey
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-18       Impact factor: 3.622

5.  Evaluation of cellular fibronectin plasma levels as a useful staging tool in different stages of transitional cell carcinoma of the bladder and renal cell carcinoma.

Authors:  A Hegele; R Hofmann; B Kosche; J Kropf
Journal:  Biomark Insights       Date:  2007-02-07

6.  Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans.

Authors:  Hyun-Jeong Ra; Susanna Harju-Baker; Fuming Zhang; Robert J Linhardt; Carole L Wilson; William C Parks
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

7.  [Transitional cell carcinoma of the bladder. Evaluation of plasma levels of cellular fibronectin as a stage-dependent marker].

Authors:  A Hegele; B Kosche; A J Schrader; S Sevinc; P J Olbert; R Hofmann; J Kropf
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

8.  Elevated S100A9 expression in chronic rhinosinusitis coincides with elevated MMP production and proliferation in vitro.

Authors:  Marina Boruk; Christopher Railwah; Alnardo Lora; Sridesh Nath; Derek Wu; Lillian Chow; Panid Borhanjoo; Abdoulaye J Dabo; Sadakat Chowdhury; Ryan Kaiser; Robert F Foronjy; Richard Rosenfeld; Patrick Geraghty
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.